NIH-Funded Study Suggests GLP-1 Drug Slows Aging in Mice

An NIH-funded study in mice suggests a GLP-1 drug, similar to semaglutide, can slow the aging process and extend lifespan. Older female mice treated daily for three months exhibited improved muscular and cognitive function, coordination, balance, and endurance, living approximately 100 days longer. These findings indicate potential anti-aging effects, mirroring benefits seen with calorie restriction.